Reset filter
Palabras clave
C95.9 ×
Mostrar más Palabras clave
Tabla de contenido
  1. 1. Ensayo clínico
  2. 2. Documentación de rutina
  3. 3. Estudio de registro / cohorte
  4. 4. Seguro de calidad
  5. 5. Estándar de datos
  6. 6. Resultado reportado por el paciente
  7. 7. Especialidad médica
Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

380 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

CALGB-10501 Diagnostic Blood/Bone Marrow Evaluation Form NCT00513747

- 20/9/21 - 1 formulario, 6 itemgroups, 30 items, 1 idioma
Itemgroups: Header, Patient demographics, FOR INSTITUTIONS WITH ACCESS TO THE CALGB LABTRAK, Biopsy specimen, Contact information, Footer module
CALGB-10501 Diagnostic Blood/Bone Marrow Evaluation Form NCT00513747 Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=3410554E-9E96-2D64-E044-0003BA3F9857

Eligibility DRKS00003838 NCT00701766 Leukemia, Myeloid, Acute - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 21 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00701766

Eligibility DRKS00002025 NCT00606723 Acute Myeloid Leukemia (AML) - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 9 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00606723

Eligibility DRKS00003742 NCT00632749 Leukemia, Myeloid, Acute - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 25 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00632749

Eligibility NCT00560794 Acute Lymphoblastic Leukemia - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 24 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00560794

E2905 On-Study Form NCT00843882

- 20/9/21 - 1 formulario, 5 itemgroups, 47 items, 1 idioma
Itemgroups: Header, Data amendment, Patient Information, Prior Treatment, Comments
E2905 On-Study Form NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EA9BECA-9DE5-1273-E044-0003BA3F9857

Registration Leukemia COG AALL08B1 NCT01142427

- 20/9/21 - 1 formulario, 9 itemgroups, 72 items, 1 idioma
Itemgroups: Stratification, PATIENT CRITERIA, Consents I, Exclusion Criteria, Organ Function - Non Hematological, Organ Function - Hematological, Inclusion Criteria, Stratification II, CONSENT FOR RESEARCH STUDIES
COG AALL08B1 OPEN Registration Worksheet NCT01142427 Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ADF3C25C-AD44-CFB2-E040-BB89AD4343C8

Leukemia DRKS00003845 NCT00651261 On-Study - CALGB: 10603 On-Study Form - 2719613v1.0 - CALGB: 10603 On-Study Form

- 20/9/21 - 1 formulario, 10 itemgroups, 46 items, 1 idioma
Itemgroups: Header, Header Module, Patient Description, Leukemia Classification (WHO/FAB), Clinical Onset of AML, Extramedullary Disease Involvement, ORGAN INVOLVEMENT, Current Symptoms, Lab Data at Study Entry, Footer Module
CALGB: 10603 On-Study Form Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=437820BA-0A20-2BB7-E044-0003BA3F9857

E2905 Baseline Step 1 Disease Evaluation Form NCT00843882

- 20/9/21 - 1 formulario, 8 itemgroups, 56 items, 1 idioma
Itemgroups: Header, Patient demographics, Data amendment, Pre-registration Hematology/chemistry, Leukemia Assessment, International Prognostic Score (IPSS), Baseline Abnormalities, Comments
E2905 Baseline Step 1 Disease Evaluation Form NCT00843882 Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=0EAB4E64-72BE-45B3-E044-0003BA3F9857

Initial assessment Leukemia AML-AZA in elderly patients NCT00915252

- 20/9/21 - 1 formulario, 10 itemgroups, 80 items, 2 idiomas
Itemgroups: Patient data, Clinical findings, Comorbidities, Differential blood count, Clinical Chemistry, Knochenmarkuntersuchung, Zytologie, FAB-Klassifikation, Molekulargenetik, Unterschrift
A randomized, multi-center phase II trial to assess the efficacy of 5-azacytidine added to standard primary therapy in elderly patients with newly diagnosed AML NCT00915252

Eligibility NCT00373373 Acute Myeloid Leukemia - Eligibility

- 20/9/21 - 1 formulario, 2 itemgroups, 28 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00373373

E2902 On-Study Form - Form 2050 NCT00093470

- 20/9/21 - 1 formulario, 9 itemgroups, 42 items, 1 idioma
Itemgroups: Header, Evaluation of Disease/Cancer, Current Remission, Current CR Confirmation, Bone Marrow Biopsy/Aspirate, At Any Time, Current Performance Status, Baseline Abnormalities, Comments
E2902 On-Study Form - Form 2050 NCT00093470 Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=DBF6D3B9-09FD-06C3-E034-0003BA12F5E7

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial